vs
Side-by-side financial comparison of TRANSCONTINENTAL REALTY INVESTORS INC (TCI) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $12.1M, roughly 1.1× TRANSCONTINENTAL REALTY INVESTORS INC). TRANSCONTINENTAL REALTY INVESTORS INC runs the higher net margin — 68.8% vs -73.9%, a 142.6% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 2.3%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 0.7%).
Transcontinental Realty Investors Inc. (TCI) is a U.S.-based real estate investment firm that owns, operates and develops a diversified portfolio of residential, commercial and mixed-use properties across core U.S. regional markets. It pursues long-term value growth via strategic property acquisitions, efficient asset management and tailored leasing solutions for individual and business tenants.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
TCI vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.1M | $13.2M |
| Net Profit | $8.3M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | -28.9% | -24.8% |
| Net Margin | 68.8% | -73.9% |
| Revenue YoY | 2.3% | 59.8% |
| Net Profit YoY | 7577.8% | 3.5% |
| EPS (diluted) | $0.97 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.1M | $13.2M | ||
| Q3 25 | $12.8M | $11.6M | ||
| Q2 25 | $12.2M | $11.2M | ||
| Q1 25 | $12.0M | $9.2M | ||
| Q4 24 | $11.8M | $8.3M | ||
| Q3 24 | $11.6M | $7.3M | ||
| Q2 24 | $11.8M | $7.4M | ||
| Q1 24 | $11.9M | $6.5M |
| Q4 25 | $8.3M | $-9.8M | ||
| Q3 25 | $724.0K | $-10.8M | ||
| Q2 25 | $169.0K | $-8.3M | ||
| Q1 25 | $4.6M | $-10.4M | ||
| Q4 24 | $108.0K | $-10.1M | ||
| Q3 24 | $1.7M | $-2.4M | ||
| Q2 24 | $1.5M | $-4.3M | ||
| Q1 24 | $2.5M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | -28.9% | -24.8% | ||
| Q3 25 | -10.9% | -77.9% | ||
| Q2 25 | -6.8% | -65.4% | ||
| Q1 25 | -5.3% | -79.9% | ||
| Q4 24 | -14.3% | -91.8% | ||
| Q3 24 | -14.4% | -118.9% | ||
| Q2 24 | -9.2% | -111.0% | ||
| Q1 24 | -11.2% | -180.8% |
| Q4 25 | 68.8% | -73.9% | ||
| Q3 25 | 5.6% | -93.5% | ||
| Q2 25 | 1.4% | -73.9% | ||
| Q1 25 | 38.5% | -113.2% | ||
| Q4 24 | 0.9% | -122.4% | ||
| Q3 24 | 14.7% | -32.6% | ||
| Q2 24 | 12.7% | -58.8% | ||
| Q1 24 | 21.4% | -204.5% |
| Q4 25 | $0.97 | $-0.22 | ||
| Q3 25 | $0.08 | $-0.96 | ||
| Q2 25 | $0.02 | $-0.27 | ||
| Q1 25 | $0.53 | $-0.39 | ||
| Q4 24 | $0.01 | $-0.38 | ||
| Q3 24 | $0.20 | $-0.12 | ||
| Q2 24 | $0.17 | $-0.21 | ||
| Q1 24 | $0.30 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.0M | $20.4M |
| Total DebtLower is stronger | $210.8M | — |
| Stockholders' EquityBook value | $846.7M | $-33.9M |
| Total Assets | $1.1B | $35.3M |
| Debt / EquityLower = less leverage | 0.25× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.0M | $20.4M | ||
| Q3 25 | $82.7M | $22.7M | ||
| Q2 25 | $73.5M | $26.5M | ||
| Q1 25 | $88.6M | $13.0M | ||
| Q4 24 | $99.7M | $8.5M | ||
| Q3 24 | $131.6M | $11.3M | ||
| Q2 24 | $127.5M | $16.5M | ||
| Q1 24 | $130.8M | $4.0M |
| Q4 25 | $210.8M | — | ||
| Q3 25 | $223.5M | — | ||
| Q2 25 | $212.4M | — | ||
| Q1 25 | $198.2M | — | ||
| Q4 24 | $181.9M | — | ||
| Q3 24 | $180.3M | — | ||
| Q2 24 | $177.4M | — | ||
| Q1 24 | $178.3M | — |
| Q4 25 | $846.7M | $-33.9M | ||
| Q3 25 | $838.4M | $-26.7M | ||
| Q2 25 | $837.7M | $-19.4M | ||
| Q1 25 | $837.3M | $-34.4M | ||
| Q4 24 | $832.3M | $-25.9M | ||
| Q3 24 | $832.2M | $-20.4M | ||
| Q2 24 | $830.4M | $-25.3M | ||
| Q1 24 | $828.9M | $-36.0M |
| Q4 25 | $1.1B | $35.3M | ||
| Q3 25 | $1.1B | $36.5M | ||
| Q2 25 | $1.1B | $41.3M | ||
| Q1 25 | $1.1B | $28.6M | ||
| Q4 24 | $1.1B | $24.0M | ||
| Q3 24 | $1.1B | $27.5M | ||
| Q2 24 | $1.0B | $32.4M | ||
| Q1 24 | $1.0B | $17.9M |
| Q4 25 | 0.25× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.22× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | -0.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $-2.5M | ||
| Q3 25 | $8.2M | $-3.7M | ||
| Q2 25 | $-2.9M | $-7.3M | ||
| Q1 25 | $-7.4M | $-4.5M | ||
| Q4 24 | $1.3M | $-5.7M | ||
| Q3 24 | $13.7M | $-10.8M | ||
| Q2 24 | $-511.0K | $-13.4M | ||
| Q1 24 | $3.9M | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | -0.35× | — | ||
| Q3 25 | 11.28× | — | ||
| Q2 25 | -17.24× | — | ||
| Q1 25 | -1.61× | — | ||
| Q4 24 | 12.13× | — | ||
| Q3 24 | 8.03× | — | ||
| Q2 24 | -0.34× | — | ||
| Q1 24 | 1.52× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
